VANCOUVER, BC — /PRNewswire/ — With the foreseeable increase in outdoor travelling in the near future, as well as the ever-expanding prospects of self-driving vehicles that have been reported to… Read More
MISSISSAUGA, ON — Gilead Sciences Canada, Inc. (Gilead Canada) announced today that Christophe Griolet joined the organization as Vice President and General Manager. In his new role, Griolet will be responsible… Read More
European Medicines Agency (EMA) validates AbbVie’s Marketing Authorization Application; Genmab submits Biologics License Application to U.S. Food and Drug Administration (FDA) The submissions are supported by the EPCORE™ NHL-1 open-label, multi-center… Read More
Bioboost Synbio Inc. (www.bioboostsynbio.com) received their Notice of Allowance from the United States Patent and Trademark Office (USPTO) to secure their first patent in the USA. Bioboost is a synthetic… Read More
First and only biologic to consistently and significantly reduce exacerbations in a broad population of severe asthma patients MISSISSAUGA, ON — Today, AstraZeneca and Amgen announced the Canadian availability of… Read More
